Patient Guide: A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 13 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06219356
Status: 🟢 Enrolling Now
Condition: Non-Hodgkin Lymphoma
Phase: PHASE1

Where You Can Participate

This study is available at 13 locations across the country.

Top locations include:
  • • Beijing, Beijing
  • • Beijing, Beijing
  • • Xiamen, Fujian
  • • And 10 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas - Join Clinical Trial NCTNCT06219356

How to Join This Clinical Trial - NCTNCT06219356

Learn how to participate in this PHASE1 trial studying an investigational therapy for Non-Hodgkin Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Hodgkin Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Hodgkin Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06219356 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Beijing, Beijing 100142 - China

Status: RECRUITING

Clinical Research Site

Beijing, Beijing 100191 - China

Status: RECRUITING

Clinical Research Site

Xiamen, Fujian 361003 - China

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510060 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 450003 - China

Status: RECRUITING

Clinical Research Site

Wuhan, Hubei 430023 - China

Status: RECRUITING

Clinical Research Site

Changsha, Hunan 410000 - China

Status: RECRUITING

Clinical Research Site

Nanchang, Jiangxi 330029 - China

Status: RECRUITING

Clinical Research Site

Shenyang, Liaoning 110004 - China

Status: RECRUITING

Clinical Research Site

Shanghai, Shanghai 200032 - China

Status: RECRUITING

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Non-Hodgkin Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships